Exemestane improves survival compared with megestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial European - Kaufmann, M, Bajetta, E, Dirix, LY, Fein, LE, Jones, SE, Cervek, J (Journal of Cancer, 2000)